Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx,”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the 22nd MEDEXPO Africa 2022, held June 9-11 in Nairobi, Kenya. The largest international medical trade exhibition in the country features exhibitors from over 30 countries, all profiling innovative solutions from leaders in the medical technology industry, and targeted toward buyers from across the continent seeking new...